<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2020.1011398</article-id><article-id pub-id-type="publisher-id">ACM-38748</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20201100000_22964280.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  血清尿酸和胱抑素C水平与冠脉病变程度的相关性分析
  Correlation Analysis between Serum Uric Acid and Cystatin C Levels and the Degree of Coronary Artery Disease
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>滕</surname><given-names>达</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>张</surname><given-names>蕊</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>吕</surname><given-names>晓冰</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>李</surname><given-names>荣</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>辛</surname><given-names>辉</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>青岛大学医学部，山东 青岛</addr-line></aff><aff id="aff4"><addr-line>青岛大学附属医院心电图室，山东 青岛</addr-line></aff><aff id="aff3"><addr-line>青岛大学附属医院心血管内科，山东 青岛</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>04</day><month>11</month><year>2020</year></pub-date><volume>10</volume><issue>11</issue><fpage>2621</fpage><lpage>2627</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  
    目的：探讨血尿酸(UA)和胱抑素C (Cyc-c)与冠脉病变程度的相关性。方法：选取2019年1月至12月拟诊为“冠心病”于青岛大学附属医院住院患者320例。根据冠状动脉造影结果分为CHD−组100例，CHD+组220例，其中单支病变60例，双支病变60例及三支病变100例；且CHD+组应用SYNTAX评分系统评分。比较不同组病人UA和Cyc-C水平，并应用ROC曲线来预测两个指标对冠心病的预测能力。结果：1) CHD+组的UA和Cyc-c明显高于对照组，差别具有统计学意义(P &lt; 0.05)。其中多支病变组的UA明显高于双支和单支病变组，差别具有统计学意义(P &lt; 0.05)；多支病变组的Cyc-C明显高于单支和双支病变组，差别具有统计学意义(P &lt; 0.05)；但单支病变组的Cyc-c水平和对照组未见明显统计学差异(P &gt; 0.05)。2) 进行回归分析结果表明UA和Cyc-C是冠心病的独立影响因子。3) ROC曲线显示UA (AUC为0.858)和Cyc-c (AUC为0.753)对CHD有一定预测价值。结论：UA和Cyc-C可在一定程度上可以预测冠心病及冠脉病变的严重程度，为冠心病的诊治提供一些新的治疗思路。
    Objective: To explore the correlation between blood uric acid (UA) and cystatin C (Cyc-c) and the degree of coronary artery lesions. Methods: 320 inpatients being suspected as “coronary heart disease” in the Affiliated Hospital of Qingdao University from January to December 2019 were chosen. According to the results of coronary angiography, those inpatients were divided into two groups: CHD− group with 100 cases and CHD+ group with 220 cases including 60 cases of single-vessel disease, 60 cases of double-vessel disease and 100 cases of multiple-vessel disease. The SYNTAX scoring system was used for CHD+ group. The UA and Cyc-C levels of inpatients in the two groups were compared and the ROC curves were employed to predict the predictive ability of the two indicators for coronary heart disease. Results: The UA and Cyc-c levels of the CHD+ group were significantly higher than those of the control group, and the difference was statistically significant (P &lt; 0.05), among which, the UA level of the multi-vessel disease group was significantly higher than that of the double-vessel and single-vessel disease groups, and the difference was statistically significant (P &lt; 0.05); the Cyc-C level of the multi-vessel disease group was significantly higher than that of the last two disease groups, too, and the difference was also statistically significant (P &lt; 0.05); but the Cyc-c level of the single-vessel disease group and the control group were not obviously statistically different (P &gt; 0.05). The ROC curve showed that UA (AUC being 0.858) and Cyc-c (AUC being 0.753) had certain predictive value for CHD. Conclusions: UA and Cyc-C can predict the severity of coronary heart disease and coronary artery disease to a certain extent, and provide some new therapy ideas for the diagnosis and treatment of coronary heart disease. 
  
 
</p></abstract><kwd-group><kwd>冠心病，尿酸，胱抑素C, Coronary Heart Disease</kwd><kwd> Uric Acid</kwd><kwd> Cystatin C</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>摘要</title><p>目的：探讨血尿酸(UA)和胱抑素C (Cyc-c)与冠脉病变程度的相关性。方法：选取2019年1月至12月拟诊为“冠心病”于青岛大学附属医院住院患者320例。根据冠状动脉造影结果分为CHD−组100例，CHD+组220例，其中单支病变60例，双支病变60例及三支病变100例；且CHD+组应用SYNTAX评分系统评分。比较不同组病人UA和Cyc-C水平，并应用ROC曲线来预测两个指标对冠心病的预测能力。结果：1) CHD+组的UA和Cyc-c明显高于对照组，差别具有统计学意义(P &lt; 0.05)。其中多支病变组的UA明显高于双支和单支病变组，差别具有统计学意义(P &lt; 0.05)；多支病变组的Cyc-C明显高于单支和双支病变组，差别具有统计学意义(P &lt; 0.05)；但单支病变组的Cyc-c水平和对照组未见明显统计学差异(P &gt; 0.05)。2) 进行回归分析结果表明UA和Cyc-C是冠心病的独立影响因子。3) ROC曲线显示UA (AUC为0.858)和Cyc-c (AUC为0.753)对CHD有一定预测价值。结论：UA和Cyc-C可在一定程度上可以预测冠心病及冠脉病变的严重程度，为冠心病的诊治提供一些新的治疗思路。</p></sec><sec id="s2"><title>关键词</title><p>冠心病，尿酸，胱抑素C</p></sec><sec id="s3"><title>Correlation Analysis between Serum Uric Acid and Cystatin C Levels and the Degree of Coronary Artery Disease<sup> </sup></title><p>Da Teng<sup>1*</sup>, Rui Zhang<sup>2</sup>, Xiaobing Lv<sup>3</sup>, Rong Li<sup>3</sup>, Hui Xin<sup>2#</sup></p><p><sup>1</sup>Medical Department, Qingdao University, Qingdao Shandong</p><p><sup>2</sup>Department of Cardiovascular Medicine, Affiliated Hospital of Qingdao University, Qingdao Shandong</p><p><sup>3</sup>ECG Room, Affiliated Hospital of Qingdao University, Qingdao Shandong</p><p><img src="//html.hanspub.org/file/32-1571648x5_hanspub.png" /></p><p>Received: Nov. 2<sup>nd</sup>, 2020; accepted: Nov. 18<sup>th</sup>, 2020; published: Nov. 25<sup>th</sup>, 2020</p><p><img src="//html.hanspub.org/file/32-1571648x6_hanspub.png" /></p></sec><sec id="s4"><title>ABSTRACT</title><p>Objective: To explore the correlation between blood uric acid (UA) and cystatin C (Cyc-c) and the degree of coronary artery lesions. Methods: 320 inpatients being suspected as “coronary heart disease” in the Affiliated Hospital of Qingdao University from January to December 2019 were chosen. According to the results of coronary angiography, those inpatients were divided into two groups: CHD− group with 100 cases and CHD+ group with 220 cases including 60 cases of single-vessel disease, 60 cases of double-vessel disease and 100 cases of multiple-vessel disease. The SYNTAX scoring system was used for CHD+ group. The UA and Cyc-C levels of inpatients in the two groups were compared and the ROC curves were employed to predict the predictive ability of the two indicators for coronary heart disease. Results: The UA and Cyc-c levels of the CHD+ group were significantly higher than those of the control group, and the difference was statistically significant (P &lt; 0.05), among which, the UA level of the multi-vessel disease group was significantly higher than that of the double-vessel and single-vessel disease groups, and the difference was statistically significant (P &lt; 0.05); the Cyc-C level of the multi-vessel disease group was significantly higher than that of the last two disease groups, too, and the difference was also statistically significant (P &lt; 0.05); but the Cyc-c level of the single-vessel disease group and the control group were not obviously statistically different (P &gt; 0.05). The ROC curve showed that UA (AUC being 0.858) and Cyc-c (AUC being 0.753) had certain predictive value for CHD. Conclusions: UA and Cyc-C can predict the severity of coronary heart disease and coronary artery disease to a certain extent, and provide some new therapy ideas for the diagnosis and treatment of coronary heart disease.</p><p>Keywords:Coronary Heart Disease, Uric Acid, Cystatin C</p><disp-formula id="hanspub.38748-formula21"><graphic xlink:href="//html.hanspub.org/file/32-1571648x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2020 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/32-1571648x8_hanspub.png" /> <img src="//html.hanspub.org/file/32-1571648x9_hanspub.png" /></p></sec><sec id="s5"><title>1. 引言</title><p>冠状动脉粥样硬化性心脏病(CHD)已成为目前威胁人类生命健康的主要疾病之一，寻找新的危险因素，尽早干预，为冠心病提供新的治疗思路迫在眉睫，随着近来流行病学调查的广泛开展，尿酸(UA)与胱抑素C (Cyc-C)与冠心病的相关性也逐渐得到认识，但二者是否作为冠心病的独立危险因素，二者对冠心病的发生是否有叠加效应也存在争议。本文通过对冠脉造影患者血清UA和Cyc-C测定，并进行相关性分析，探讨血清UA和Cyc-C与冠心病的发生和冠脉病变严重程度的相关性。</p></sec><sec id="s6"><title>2. 研究对象及方法</title><sec id="s6_1"><title>2.1. 对象及分组</title><p>选取2019年1月至12月拟诊为“冠心病”于青岛大学附属医院住院患者320例。所有研究对象均行冠脉造影(coronary angiography, CAG)，其中男性190例，平均年龄为66.04 &#177; 10.01岁，绝经后女性130例，平均年龄为65.21 &#177; 6.93岁。以CAG为金标准，冠状动脉病变最严重处狭窄 ≥50%的患者为冠心病组，共220例；冠状动脉无狭窄或最严重处狭窄 &lt;50%的患者为对照组。同时将冠心病组分为三个亚组：单支病变组(累及左前降支、左回旋支、右冠状动脉任一主血管) 60例，双支病变组(累及两支主血管或单独累及左主干) 60例，三支病变组(累及三支主血管或累及左主干和任一主血管) 100例。所有研究对象均签署知情同意书并通过医院伦理委员会的审查。</p></sec><sec id="s6_2"><title>2.2. 研究方法</title><p>病人住院晚餐后禁食8~10 h，次日清晨抽血测定肝功能、总胆固醇(TC)，低密度脂蛋白(LDL-C)，甘油三酯(TG)，空腹血糖(GLU0h)，肌酐(Cr)，尿素氮(BUN)尿酸(UA)和胱抑素C (Cyc-C)。冠脉造影由我院技术熟练的心血管内科医师进行操作，并判断有无冠脉病变，根据SYNTAX评分系统进行评分，分数越高，表示病变越严重 [<xref ref-type="bibr" rid="hanspub.38748-ref1">1</xref>]。</p></sec><sec id="s6_3"><title>2.3. 排除标准</title><p>1) 治疗后的冠心病或长期服用他汀类药物、心肌炎、心肌病或瓣膜性心脏病、急慢性心力衰竭；2) 急性脑梗死或精神疾病；3) 严重肝肾功能损伤、呼吸衰竭；4) 恶性肿瘤或血液系统疾病；5) 感染性或传染性疾病；6) 风湿免疫系统疾病等。</p></sec><sec id="s6_4"><title>2.4. 统计学方法</title><p>采用SPSS22.0软件进行统计学分析，正态分布的计量资料数据以x &#177; s表示，进行方差齐性检验后，组间比较采用独立样本t检验；计数资料组间比较采用卡方检验；对疾病严重程度预测有效性采用ROC曲线进行分析。</p></sec></sec><sec id="s7"><title>3. 结果</title><sec id="s7_1"><title>3.1. 不同组间一般资料及血清学指标比较</title><p>CHD+组与CHD-组间在性别、年龄、高血压和糖尿病病史、LDL-C、TC和UA、Cyc-C之间，差距有显著性差异(P &lt; 0.05)，检测病人在入院时收缩压、GLU0h、Cr、BUN、ALT及TG时两组未见明显统计学差异。见表1。</p><table-wrap-group id="1"><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Comparison of basic data between control group and coronary heart disease group ( x &#175; &#177; s</title></caption><table-wrap id="1_1"><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >CHD<sup>−</sup> (n = 100)</th><th align="center" valign="middle" >CHD<sup>+</sup> (n = 220)</th><th align="center" valign="middle" ></th><th align="center" valign="middle" ></th></tr></thead><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >c<sup>2</sup>或t</td><td align="center" valign="middle" >P值</td></tr><tr><td align="center" valign="middle" >年龄</td><td align="center" valign="middle" >60.66&#177;8.39</td><td align="center" valign="middle" >68&#177;8.14</td><td align="center" valign="middle" >−3.97</td><td align="center" valign="middle" >&lt;0.01</td></tr><tr><td align="center" valign="middle" >性别 男</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >150</td><td align="center" valign="middle" >−3.47</td><td align="center" valign="middle" >&lt;0.05</td></tr><tr><td align="center" valign="middle" >女</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >高血压(例/%)</td><td align="center" valign="middle" >60/120</td><td align="center" valign="middle" >150/68.2</td><td align="center" valign="middle" >−1.43</td><td align="center" valign="middle" >&lt;0.05</td></tr><tr><td align="center" valign="middle" >糖尿病(例/%)</td><td align="center" valign="middle" >20/40</td><td align="center" valign="middle" >66/60</td><td align="center" valign="middle" >−1.35</td><td align="center" valign="middle" >&lt;0.05</td></tr><tr><td align="center" valign="middle" >收缩压</td><td align="center" valign="middle" >139.06 &#177; 16.965</td><td align="center" valign="middle" >139.04 &#177; 18.81</td><td align="center" valign="middle" >0.01</td><td align="center" valign="middle" >0.99</td></tr><tr><td align="center" valign="middle" >GLU0h (mmol/L)</td><td align="center" valign="middle" >6.14 &#177; 1.79</td><td align="center" valign="middle" >7.05 &#177; 6.36</td><td align="center" valign="middle" >−1.35</td><td align="center" valign="middle" >0.34</td></tr><tr><td align="center" valign="middle" >BUN (μmol/L)</td><td align="center" valign="middle" >6.89 &#177; 3.70</td><td align="center" valign="middle" >6.20 &#177; 1.99</td><td align="center" valign="middle" >1.24</td><td align="center" valign="middle" >0.13</td></tr></tbody></table></table-wrap><table-wrap id="1_2"><table><tbody><thead><tr><th align="center" valign="middle" >Cr (μmol/L)</th><th align="center" valign="middle" >67.98 &#177; 23.21</th><th align="center" valign="middle" >66.21 &#177; 22.71</th><th align="center" valign="middle" >0.45</th><th align="center" valign="middle" >0.65</th></tr></thead><tr><td align="center" valign="middle" >LDL-C (mmol/L)</td><td align="center" valign="middle" >2.31 &#177; 0.78</td><td align="center" valign="middle" >3.01 &#177; 0.75</td><td align="center" valign="middle" >−5.45</td><td align="center" valign="middle" >&lt;0.05</td></tr><tr><td align="center" valign="middle" >TG (mmol/L)</td><td align="center" valign="middle" >1.61 &#177; 0.93</td><td align="center" valign="middle" >1.47 &#177; 0.85</td><td align="center" valign="middle" >0.92</td><td align="center" valign="middle" >0.37</td></tr><tr><td align="center" valign="middle" >TC (mmol/L)</td><td align="center" valign="middle" >4.05 &#177; 0.8</td><td align="center" valign="middle" >4.81 &#177; 1.00</td><td align="center" valign="middle" >−4.72</td><td align="center" valign="middle" >&lt;0.05</td></tr><tr><td align="center" valign="middle" >ALT (u/L)</td><td align="center" valign="middle" >44.3 &#177; 71.65</td><td align="center" valign="middle" >31.20 &#177; 38.47</td><td align="center" valign="middle" >1.50</td><td align="center" valign="middle" >0.14</td></tr><tr><td align="center" valign="middle" >UA (μmol/L)</td><td align="center" valign="middle" >310.04 &#177; 71.65</td><td align="center" valign="middle" >400.42 &#177; 69.85</td><td align="center" valign="middle" >−8.50</td><td align="center" valign="middle" >&lt;0.05</td></tr><tr><td align="center" valign="middle" >Cyc-C (mg/L)</td><td align="center" valign="middle" >0.99 &#177; 0.87</td><td align="center" valign="middle" >1.79 &#177; 0.69</td><td align="center" valign="middle" >−6.25</td><td align="center" valign="middle" >&lt;0.05</td></tr></tbody></table></table-wrap></table-wrap-group><p>表1. CHD−组与CHD+组一般资料和血清学指标比较 ( &#177; s)</p></sec><sec id="s7_2"><title>3.2. 患者冠脉不同病变支数间UA和Cyc水平的比较</title><p>单因素方差分析发现，对照组与单支病变组、双支病变组及三支病变组UA和Cyc-c水平有统计学差异(F尿酸 = 31.74，P&lt;0.05；Fcyc-c = 21.70，P &lt; 0.05)。多重因素比较显示对照组与单支、双支及三支病变组相比，UA水平有统计学意义(t值分别为−3.63、−5.72、−9.83，p &lt; 0.05；)，单支与双支、三支病变(t值分别为−2.02，−4.87；p &lt; 0.05)和双支与三支(t = −2.29, p &lt; 0.05)组比较有显著性差异，即随着冠脉病变支数的增加，UA水平也增加。多重因素比较显示对照组与双支及三支病变组相比，Cyc水平有统计学意义(t值分别为2.67、−5.35，p &lt; 0.05；)，单支与双支、三支病变(t值分别为−4.25，−7.52；p &lt; 0.05)和双支与三支(t = −4.00, p &lt; 0.05)组比较有显著性差异但，对照组与单支病变组间的差异无统计学意义(t = 1.23, P &gt; 0.05)。见表2。</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Comparison of different coronary artery diseased branche</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >组别</th><th align="center" valign="middle" >例数(人)</th><th align="center" valign="middle" >UA (μmol)</th><th align="center" valign="middle" >Cyc (mg/L)</th><th align="center" valign="middle" >SYNTAX积分</th></tr></thead><tr><td align="center" valign="middle" >无病变组</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >310.04 &#177; 58.67</td><td align="center" valign="middle" >0.99 &#177; 0.87</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >单支病变组</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >359.67 &#177; 60.18<sup>※</sup></td><td align="center" valign="middle" >1.31 &#177; 0.55</td><td align="center" valign="middle" >11.4 &#177; 4.73<sup>※</sup></td></tr><tr><td align="center" valign="middle" >双支病变组</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >394.03 &#177; 71.20<sup>※◎</sup></td><td align="center" valign="middle" >1.71 &#177; 0.39<sup>※◎</sup></td><td align="center" valign="middle" >24.5 &#177; 5.13<sup>※◎</sup></td></tr><tr><td align="center" valign="middle" >三支病变组</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >428.72 &#177; 62.06<sup>※◎●</sup></td><td align="center" valign="middle" >2.13 &#177; 0.72<sup>※◎●</sup></td><td align="center" valign="middle" >40.39 &#177; 0.73<sup>※◎●</sup></td></tr><tr><td align="center" valign="middle" >F</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >31.74</td><td align="center" valign="middle" >21.70</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >P</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.000</td><td align="center" valign="middle" >0.000</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>表2. 不同冠脉病变支数组间的比较</p><p>注：<sup>※</sup>表示与对照组相比P &lt; 0.05，<sup>◎</sup>表示与单支病变组相比P &lt; 0.05，<sup>●</sup>与双支病变组相比P &lt; 0.05。</p></sec><sec id="s7_3"><title>3.3. 冠心病、UA和Cyc-c与各变量间的关系</title><p>相关性分析显示：单因素Logistic回归分析显示，纳入自变量为年龄(赋值0 =&lt; 65岁，1 =&gt; 65岁)、性别(赋值1 = 男，2 = 女)、高血压史(赋值0 = 无，0 = 有)、糖尿病史(赋值0 = 无，1 = 有)、吸烟(赋值0 = 无，1 = 有)、BMI、LDL-C、三酰甘油、UA、Cyc-C等指标，因变量为组别(赋值0 = 对照组，1 = 冠心病组)，自变量 男性、年龄 &gt; 65岁，糖尿病、吸烟、低密度脂蛋白、总胆固醇、UA、Cyc-C是冠心病的危险因素，且P &lt; 0.05，具有统计学意义(见表3)；将单因素分析有统计学意义的变量作为自变量，以是否发生冠心病为因变量建立Logistic回归模型，结果显示，UA和Cyc-C是冠心病的独立危险因素(t<sub>UA</sub> = 5.201, P &lt; 0.05; <sub>tCyc-c</sub> = 4.488, P &lt; 0.05)，见表4。</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Single factor logistic regression analysis of coronary heart diseas</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >变量</th><th align="center" valign="middle" >回归系数</th><th align="center" valign="middle" >P</th></tr></thead><tr><td align="center" valign="middle" >性别</td><td align="center" valign="middle" >−1.858</td><td align="center" valign="middle" >0.004</td></tr><tr><td align="center" valign="middle" >年龄</td><td align="center" valign="middle" >2.150</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle" >吸烟</td><td align="center" valign="middle" >0.012</td><td align="center" valign="middle" >0.023</td></tr><tr><td align="center" valign="middle" >低密度脂蛋白(mmol/L)</td><td align="center" valign="middle" >0.838</td><td align="center" valign="middle" >0.061</td></tr><tr><td align="center" valign="middle" >总胆固醇(mmol/L)</td><td align="center" valign="middle" >0.916</td><td align="center" valign="middle" >0.022</td></tr><tr><td align="center" valign="middle" >糖尿病病史</td><td align="center" valign="middle" >0.013</td><td align="center" valign="middle" >0.013</td></tr><tr><td align="center" valign="middle" >UA (μmol/L)</td><td align="center" valign="middle" >0.025</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >Cyc-C (mg/L)</td><td align="center" valign="middle" >1.234</td><td align="center" valign="middle" >0.002</td></tr></tbody></table></table-wrap><p>表3. 冠心病单因素Logistic回归分析</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Multiple regression analysis of influencing factors of coronary heart diseas</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle"  colspan="2"  >非标准化系数</th><th align="center" valign="middle" >标准系数</th><th align="center" valign="middle" >t</th><th align="center" valign="middle" >显著性</th></tr></thead><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >B</td><td align="center" valign="middle" >标准错误</td><td align="center" valign="middle" >β</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >UA</td><td align="center" valign="middle" >0.002</td><td align="center" valign="middle" >0.000</td><td align="center" valign="middle" >0.336</td><td align="center" valign="middle" >5.201</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >Cyc-C</td><td align="center" valign="middle" >0.155</td><td align="center" valign="middle" >0.034</td><td align="center" valign="middle" >0.278</td><td align="center" valign="middle" >4.488</td><td align="center" valign="middle" >0.000</td></tr></tbody></table></table-wrap><p>表4. 冠心病影响因素的多元回归分析</p></sec><sec id="s7_4"><title>3.4. 冠心病患者的UA和Cyc-C水平的ROC曲线分析</title><p>图1. CHD+组ROC曲线</p><p>在CHD+组ROC曲线中(图1)，血清UA的AUC面积为0.858，以358.5 μmol/L为诊断标准，统计学上讲敏感性为76.4%，特异性为86%。血清Cyc-C的AUC面积为0.753，以0.95 mg/L作为诊断标准，从统计学上讲诊断的敏感性、特异性分别为91.8%、60%。二者对冠心病的预测有一定价值。见表5。</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> ROC curve analysis of UA and Cyc-C levels in patients with coronary heart diseas</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >ROC曲线下面积</th><th align="center" valign="middle" >最佳临界值</th><th align="center" valign="middle" >敏感度</th><th align="center" valign="middle" >特异度</th><th align="center" valign="middle" >95%CI</th><th align="center" valign="middle" >P值</th></tr></thead><tr><td align="center" valign="middle" >UA (μmol/L)</td><td align="center" valign="middle" >0.858</td><td align="center" valign="middle" >358.5 μmol/L</td><td align="center" valign="middle" >76.4%</td><td align="center" valign="middle" >86%</td><td align="center" valign="middle" >0.797~0.919</td><td align="center" valign="middle" >&lt;0.05</td></tr><tr><td align="center" valign="middle" >Cyc-C (mg/L)</td><td align="center" valign="middle" >0.753</td><td align="center" valign="middle" >0.95 mg/L</td><td align="center" valign="middle" >71.8%</td><td align="center" valign="middle" >60%</td><td align="center" valign="middle" >0.662~0.843</td><td align="center" valign="middle" >&lt;0.05</td></tr></tbody></table></table-wrap><p>表5. 冠心病患者UA和Cyc-C水平的ROC曲线分析</p><p>注：ROC曲线下面积 &lt; 0.5没有诊断价值，曲线下面积为0.5~0.7有较低诊断价值，曲线下面积为0.7~0.9有一定的准确性，曲线下面积 &gt; 0.9为有较高的准确性。</p></sec></sec><sec id="s8"><title>4. 讨论</title><p>近年来，冠心病的发病率和死亡率呈逐年上升趋势，寻找新的危险因素并及时控制迫在眉睫，UA和Cyc-C与冠心病的相关性逐渐得到临床医师的重视。</p><p>UA是嘌呤代谢的最终产物，UA的生成过多或者排出过少都会导致高尿酸血症(HUA)，UA水平的增高究竟是冠心病危险因素的伴随现象还是导致冠心病的独立危险因素，目前尚无统一意见。著名的Framingham [<xref ref-type="bibr" rid="hanspub.38748-ref2">2</xref>] 研究观察了6763例患者，其研究观察UA与冠心病的发病率、死亡率及全因死亡之间的关系，结果指出，无论男性还是女性，在调整了冠心病的其他危险因素后，血UA水平与冠心病的发病率、死亡率及全因死亡无明显相关性。但并非所有研究都指出UA与冠心病无明显相关性，Bickel [<xref ref-type="bibr" rid="hanspub.38748-ref3">3</xref>] 等人对1071例患者进行2.2年的随访研究，经多因素的回归分析后证实尿酸水平的增高和冠心病患者的总死亡率相关且独立，因而提示尿酸为冠心病的独立预测因子。另外著名的NHANESI研究、MRFIT研究和中国的北京医院何青等人的研究均提示尿酸是冠心病的危险因素，UA每升高50~70 μmol/L，冠心病的危险性增加46%~50% [<xref ref-type="bibr" rid="hanspub.38748-ref4">4</xref>]。通常认为尿酸通过参与炎症反应，促进血小板聚集等因素参与动脉硬化的发生发展，但具体机制现在仍不十分明确，有待进一步阐述。本研究通过收集临床资料也发现冠心病患者通常有较高的UA水平，且尿酸水平逐渐升高，其在某种程度上反应冠脉病变加重。ROC曲线提示血清UA水平对冠心病的发生有一定预测价值，当血清尿酸浓度为358.5 μmol/L时，其对冠心病预测的敏感性及特异性最佳。</p><p>Cyc-C是体内的一种半胱氨酸蛋白酶抑制剂，由管家基因转录产生，可以在体内恒定产生。有研究指出Cyc-c可以影响中性粒细胞功能，参与炎症反应，从而影响动脉硬化的进程 [<xref ref-type="bibr" rid="hanspub.38748-ref5">5</xref>]。但Cyc-C与冠心病的关系各研究结论不一，2016年Sander W. [<xref ref-type="bibr" rid="hanspub.38748-ref6">6</xref>] 通过对15个前瞻性队列和1个随机临床试验进行研究，对78,641名参与者测定其血清中胱抑素C的浓度，探讨其与心血管疾病风险之间的关系，最终得出相较于胱抑素C本身，一些混杂因素如肾功能受损更能解释如冠心病等心血管临床事件，其在冠心病病因学中无明确因果作用。但本研究发现，CHD+和CHD−间Cyc-C有明显差异，AUC &gt; 0.05说明其对冠心病有一定的预测价值，与国内外一些研究类似 [<xref ref-type="bibr" rid="hanspub.38748-ref7">7</xref>] [<xref ref-type="bibr" rid="hanspub.38748-ref8">8</xref>]，其在CHD+中，多支病变组的Cyc-C水平明显高于双支及单支病变组，差异具有统计学意义(P &lt; 0.05)，但单支病变组和对照组无明显统计学差异(P &gt; 0.05)，可能原因为样本量较小，各组间的异质性较大，从而对实验结果造成偏倚。</p><p>综上所述，本研究得出UA和Cyc-C可在一定程度上可以预测冠心病及冠脉病变的严重程度，为冠心病的诊治提供一些新的治疗思路，但本研究有一定局限性，样本量较小必然会导致存在一定偏倚，使得结果可能被高估，尿酸与胱抑素C水平与冠脉病变程度的相关性分析还有待大样本数据进一步研究。</p></sec><sec id="s9"><title>文章引用</title><p>滕 达,张 蕊,吕晓冰,李 荣,辛 辉. 血清尿酸和胱抑素C水平与冠脉病变程度的相关性分析 Correlation Analysis between Serum Uric Acid and Cystatin C Levels and the Degree of Coronary Artery Disease[J]. 临床医学进展, 2020, 10(11): 2621-2627. https://doi.org/10.12677/ACM.2020.1011398</p></sec><sec id="s10"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.38748-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Farooq, V., Girasis, C., Magro, M., et al. (2013) The CABG SYNTAX Score—An Angiographic Tool to Grade the Complexity of Coronary Disease Following Coronary Artery Bypass Graft Surgery: From the SYNTAX Left Main Angiographic (SYNTAX-LE MANS) Substudy. EuroIntervention, 8, 1277-1285.  
&lt;br&gt;https://doi.org/10.4244/EIJV8I11A196</mixed-citation></ref><ref id="hanspub.38748-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Culleton, B.F., Larson, M.G., Kannel, W.B., et al. (1999) Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study. Annals of Internal Medicine, 131, 7-13.  
&lt;br&gt;https://doi.org/10.7326/0003-4819-131-1-199907060-00003</mixed-citation></ref><ref id="hanspub.38748-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Bickel, C., Rupprecht, H.J., Blankenberg, S., et al. (2002) Serum Uric Acid as an Independent Predictor of Mortality in Patients with Angiographically Proven Coronary Artery Disease. American Journal of Cardiology, 89, 12-17.  
&lt;br&gt;https://doi.org/10.1016/S0002-9149(01)02155-5</mixed-citation></ref><ref id="hanspub.38748-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">何青, 唐国栋. 高尿酸血症与冠心病[J]. 中国心血管杂志, 2016, 21(1): 1-4.</mixed-citation></ref><ref id="hanspub.38748-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Batra, A., Kapoor, A., Sharma, R.K., et al. (2012) Association of Plasma Cystatin C Levels with Angiographically Documented Coronary Artery Disease in Patients of Indian Origin. Journal of Cardiology, 59, 182-189.  
&lt;br&gt;https://doi.org/10.1016/j.jjcc.2011.11.013</mixed-citation></ref><ref id="hanspub.38748-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">van der Laan, S.W., Fall, T., Soumaré, A., et al. (2016) Cystatin C and Cardiovascular Disease: A Mendelian Randomization Study. Journal of the American College of Cardiology, 68, 934-945.  
&lt;br&gt;https://doi.org/10.1016/j.jacc.2016.05.092</mixed-citation></ref><ref id="hanspub.38748-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Wang, Y., Su, X., Zhang, W., et al. (2015) Correlation between Serum Cystatin C Level and Elderly Hypertensive Patients Combined Coronary Heart Disease. International Journal of Clinical and Experimental Medicine, 8, 6287-6290.</mixed-citation></ref><ref id="hanspub.38748-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">吴炜强, 陈燕娟, 刘少飞, 等. 胱抑素C及人血脂蛋白相关磷脂酶A2水平与冠状动脉Gensini评分相关性[J]. 汕头大学医学院学报, 2016, 29(4): 213-214, 217.</mixed-citation></ref></ref-list></back></article>